⌘K

Login Start Free

Home/Filings/4/0001062993-25-010824

4//SEC Filing

Turtle Cameron 4

Accession 0001062993-25-010824

CIK 0000907654other

View on SEC.gov Company Profile

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:13 PM ET

Size

5.5 KB

Accession

0001062993-25-010824

Insider Transaction Report

Form 4

Period: 2025-06-02

Oruka Therapeutics, Inc.ORKA

Director

Transactions

Award
Stock Option (right to buy)
2025-06-02+17,500→ 17,500 total
Exercise: $11.77Exp: 2035-06-01→ Common Stock (17,500 underlying)

Footnotes (1)

[F1]The option vests as to 1/12 of the underlying shares monthly from June 2, 2025.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Oruka Therapeutics, Inc.

CIK 0000907654

Entity typeother

Related Parties

1

filerCIK 0001758363

Filing Metadata

Form type: 4
Filed: Jun 2, 8:00 PM ET
Accepted: Jun 3, 4:13 PM ET
Size: 5.5 KB

View on SEC.gov